SG11201402108YA - Kit comprising serum replacement and labile factors - Google Patents
Kit comprising serum replacement and labile factorsInfo
- Publication number
- SG11201402108YA SG11201402108YA SG11201402108YA SG11201402108YA SG11201402108YA SG 11201402108Y A SG11201402108Y A SG 11201402108YA SG 11201402108Y A SG11201402108Y A SG 11201402108YA SG 11201402108Y A SG11201402108Y A SG 11201402108YA SG 11201402108Y A SG11201402108Y A SG 11201402108YA
- Authority
- SG
- Singapore
- Prior art keywords
- kit
- serum replacement
- labile factors
- labile
- factors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0031—Serum-free culture media
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0043—Medium free of human- or animal-derived components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/105—Insulin-like growth factors [IGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/165—Vascular endothelial growth factor [VEGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/19—Growth and differentiation factors [GDF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/395—Thyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161558740P | 2011-11-11 | 2011-11-11 | |
| PCT/US2012/064508 WO2013071151A1 (en) | 2011-11-11 | 2012-11-09 | Kit comprising serum replacement and labile factors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201402108YA true SG11201402108YA (en) | 2014-06-27 |
Family
ID=48290624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201402108YA SG11201402108YA (en) | 2011-11-11 | 2012-11-09 | Kit comprising serum replacement and labile factors |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20130130373A1 (en) |
| EP (1) | EP2776558A4 (en) |
| JP (2) | JP2014533113A (en) |
| KR (1) | KR20140099269A (en) |
| CN (1) | CN103958665A (en) |
| AU (1) | AU2012335070A1 (en) |
| BR (1) | BR112014011414A2 (en) |
| CA (1) | CA2854780A1 (en) |
| CL (1) | CL2014001181A1 (en) |
| EA (1) | EA201490945A1 (en) |
| HK (1) | HK1202133A1 (en) |
| IL (1) | IL232446A0 (en) |
| MX (1) | MX2014005723A (en) |
| SG (1) | SG11201402108YA (en) |
| WO (1) | WO2013071151A1 (en) |
| ZA (1) | ZA201403352B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106062205A (en) * | 2013-12-20 | 2016-10-26 | 基本药品有限责任公司 | Media for cell culture |
| CN104450614B (en) * | 2014-12-05 | 2017-07-07 | 上海安集协康生物技术股份有限公司 | The immunocyte serum free medium and its application method in a kind of animal protein-free source |
| JP6779616B2 (en) * | 2015-12-25 | 2020-11-04 | 富士ソフト株式会社 | NKT cell activating pharmaceutical composition, method for producing the same, and method for storing antigen-presenting cells. |
| CN107043739A (en) * | 2017-04-24 | 2017-08-15 | 浙江美保龙生物技术有限公司 | A kind of Vero cell culture solution additive and preparation method thereof, application method |
| CN107488625B (en) * | 2017-08-31 | 2018-12-21 | 广州蕊特生物科技有限公司 | A kind of fetal bovine serum replacement and its preparation method and application |
| CN108853489B (en) * | 2018-06-29 | 2019-07-02 | 陕西诺威利华生物科技有限公司 | A method of PEDV attenuated vaccine is produced using serum free medium |
| CN108815516B (en) * | 2018-06-29 | 2019-03-15 | 陕西诺威利华生物科技有限公司 | A method of PEDV inactivated vaccine is produced using serum free medium |
| WO2020142304A1 (en) * | 2019-01-03 | 2020-07-09 | Merck Sharp & Dohme Corp. | Supplemented serum-containing culture medium for enhanced arpe-19 growth and human cytomegalovirus vaccine production |
| CN109735491A (en) * | 2019-01-16 | 2019-05-10 | 广东美赛尔细胞生物科技有限公司 | A kind of serum free medium and preparation method thereof of amplifiable candidate stem cell |
| CN112608894A (en) * | 2020-12-31 | 2021-04-06 | 任建华 | Mesenchymal stem cell culture medium |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3827578A1 (en) | 1988-08-13 | 1990-02-15 | Siepmann Friedrich W | METHOD AND DEVICE FOR DETERMINING OXIDIZABLE WATER INGREDIENTS OF AN AQUEOUS SAMPLING LIQUID |
| US6048728A (en) | 1988-09-23 | 2000-04-11 | Chiron Corporation | Cell culture medium for enhanced cell growth, culture longevity, and product expression |
| JPH0322972A (en) * | 1989-01-12 | 1991-01-31 | Ajinomoto Co Inc | Serum-free culture medium |
| US5834312A (en) | 1990-01-29 | 1998-11-10 | Hy-Gene, Inc. | Process and media for the growth of human epithelia |
| US5292813A (en) | 1992-10-02 | 1994-03-08 | Exxon Research & Engineering Co. | Fullerene-grafted polymers and processes of making |
| US5641466A (en) | 1993-06-03 | 1997-06-24 | Nec Corporation | Method of purifying carbon nanotubes |
| US5558903A (en) | 1993-06-10 | 1996-09-24 | The Ohio State University | Method for coating fullerene materials for tribology |
| AU6698196A (en) | 1995-08-15 | 1997-03-12 | Universite Libre De Bruxelles | Liposomes preparation method and plant |
| EP1482031B1 (en) | 1996-08-30 | 2015-10-28 | Life Technologies Corporation | Serum-free mammalian cell culture medium, and uses thereof |
| EP0954563B1 (en) | 1996-10-10 | 2008-07-02 | Invitrogen Corporation | Animal cell culture media comprising plant-derived nutrients |
| US6692961B1 (en) * | 1996-10-11 | 2004-02-17 | Invitrogen Corporation | Defined systems for epithelial cell culture and use thereof |
| US5753088A (en) | 1997-02-18 | 1998-05-19 | General Motors Corporation | Method for making carbon nanotubes |
| ES2249928T3 (en) * | 1998-11-19 | 2006-04-01 | Organogenesis Inc. | MANIPULATED FABRIC CONSTRUCTS THROUGH BIOINGENIERIA AND METHODS TO PRODUCE AND USE THEM. |
| EP2348104A1 (en) | 1999-08-05 | 2011-07-27 | Mcl Llc | Multipotent adult stem cells and methods for isolation |
| US7455983B2 (en) * | 2000-01-11 | 2008-11-25 | Geron Corporation | Medium for growing human embryonic stem cells |
| EP1478734A4 (en) | 2002-01-25 | 2006-04-05 | Genzyme Corp | Serum-free media for chondrocytes and methods of use thereof |
| AU2003273573A1 (en) * | 2002-05-28 | 2003-12-19 | Becton, Dickinson And Company | Expansion and transdifferentiation of human acinar cells |
| EP1475434A1 (en) * | 2003-05-09 | 2004-11-10 | Oncoscience AG | Method for storing tumor cells |
| WO2005070120A2 (en) * | 2004-01-09 | 2005-08-04 | Serologicals Investment Company, Inc. | Cell culture media |
| US8252591B2 (en) * | 2004-05-07 | 2012-08-28 | Whitehead Institute For Biomedical Research | Hormone responsive tissue culture system and uses thereof |
| GB2431165B (en) | 2004-07-13 | 2009-04-01 | Geron Corp | Medium for growing human embryonic stem cells |
| JP3985046B2 (en) * | 2004-08-03 | 2007-10-03 | 国立大学法人 北海道大学 | Cytokines to activate dermal papilla cells |
| WO2006017759A2 (en) * | 2004-08-05 | 2006-02-16 | Kirin Brewery Co., Ltd. | Tumor endothelial marker-1 (tem1) binding antibodies and uses thereof |
| US7767453B2 (en) * | 2004-10-20 | 2010-08-03 | Whitehead Institute For Biomedical Research | Cultured hematopoietic stem cells and method for expansion and analysis thereof |
| AU2005330353B2 (en) | 2004-11-02 | 2010-10-14 | Ares Trading S.A. | Serum-free cell culture medium for mammalian cells |
| JP2007000077A (en) * | 2005-06-23 | 2007-01-11 | Hitachi Medical Corp | Method for serum-free culture of adherent animal cell and culture medium for serum-free culture of adherent animal cell |
| US20090148417A1 (en) | 2005-07-28 | 2009-06-11 | Brainguard Co., Ltd | Carbon nanotubes serving as stem cell scaffold |
| WO2007016366A2 (en) * | 2005-07-29 | 2007-02-08 | Yale University | Defined culture conditions of human embryonic stem cells |
| WO2007020611A2 (en) * | 2005-08-19 | 2007-02-22 | ECBIO - Investigação e Desenvolvimento em Biotecnologia, S.A. | Adult human neural stem/progenitor cells from the olfactory epithelium and olfactory lamina propria, isolation method, proliferation and differentiation in serum free culture medium and utilization for transplantation |
| US7754483B2 (en) * | 2005-11-09 | 2010-07-13 | The Penn State Research Foundation | Systems and methods for selection and maintenance of homogeneous and pluripotent human embryonic stem cells |
| JP5205275B2 (en) | 2005-12-21 | 2013-06-05 | セントクローネ インターナショナル エービー | Treatment of sporadic cancer |
| WO2007080919A1 (en) * | 2006-01-13 | 2007-07-19 | Japan Science And Technology Agency | Additive for culture medium for use in serum-free culture of animal cell, kit, and use of the additive or kit |
| CN101410509B (en) | 2006-02-23 | 2016-05-18 | 维亚赛特公司 | For cultivate can noble cells composition and method |
| JP5080779B2 (en) | 2006-10-25 | 2012-11-21 | テルモ株式会社 | Method for producing liposome preparation |
| CA2901105C (en) * | 2007-01-03 | 2018-02-13 | California Stem Cell, Inc. | Stem cell growth media and methods of making and using same |
| US8609411B2 (en) | 2007-05-04 | 2013-12-17 | Whitehead Institute For Biomedical Research | Ex vivo expansion of human hematopoietic stem cells |
| WO2008153970A1 (en) * | 2007-06-08 | 2008-12-18 | Wake Forest University Health Sciences | Selective cell therapy for the treatment of renal failure |
| EP2188367A4 (en) | 2007-08-10 | 2010-10-27 | Whitehead Biomedical Inst | Hormone responsive tissue culture system and uses thereof |
| JP5722885B2 (en) * | 2009-06-18 | 2015-05-27 | セレクティス アーベー | 3D culture system for growth and differentiation of human pluripotent stem (hPS) cells |
-
2012
- 2012-11-09 EP EP12847737.9A patent/EP2776558A4/en not_active Withdrawn
- 2012-11-09 EA EA201490945A patent/EA201490945A1/en unknown
- 2012-11-09 MX MX2014005723A patent/MX2014005723A/en unknown
- 2012-11-09 CN CN201280057698.XA patent/CN103958665A/en active Pending
- 2012-11-09 AU AU2012335070A patent/AU2012335070A1/en not_active Abandoned
- 2012-11-09 SG SG11201402108YA patent/SG11201402108YA/en unknown
- 2012-11-09 KR KR20147015315A patent/KR20140099269A/en not_active Application Discontinuation
- 2012-11-09 JP JP2014541340A patent/JP2014533113A/en active Pending
- 2012-11-09 CA CA2854780A patent/CA2854780A1/en not_active Abandoned
- 2012-11-09 US US13/673,739 patent/US20130130373A1/en not_active Abandoned
- 2012-11-09 BR BR112014011414A patent/BR112014011414A2/en not_active Application Discontinuation
- 2012-11-09 WO PCT/US2012/064508 patent/WO2013071151A1/en active Application Filing
-
2014
- 2014-05-04 IL IL232446A patent/IL232446A0/en unknown
- 2014-05-06 CL CL2014001181A patent/CL2014001181A1/en unknown
- 2014-05-09 ZA ZA2014/03352A patent/ZA201403352B/en unknown
-
2015
- 2015-03-17 HK HK15102719.9A patent/HK1202133A1/en unknown
-
2018
- 2018-01-05 JP JP2018000389A patent/JP2018085996A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BR112014011414A2 (en) | 2017-05-30 |
| IL232446A0 (en) | 2014-06-30 |
| AU2012335070A1 (en) | 2014-05-29 |
| CL2014001181A1 (en) | 2014-10-03 |
| CA2854780A1 (en) | 2013-05-16 |
| EA201490945A1 (en) | 2014-08-29 |
| MX2014005723A (en) | 2014-11-25 |
| KR20140099269A (en) | 2014-08-11 |
| WO2013071151A1 (en) | 2013-05-16 |
| US20130130373A1 (en) | 2013-05-23 |
| JP2014533113A (en) | 2014-12-11 |
| EP2776558A4 (en) | 2015-04-08 |
| EP2776558A1 (en) | 2014-09-17 |
| HK1202133A1 (en) | 2015-09-18 |
| CN103958665A (en) | 2014-07-30 |
| NZ624616A (en) | 2017-01-27 |
| JP2018085996A (en) | 2018-06-07 |
| ZA201403352B (en) | 2016-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2100034I1 (en) | Anti-angptl3 antibodies and uses thereof | |
| IL288203A (en) | Meditopes and meditope-binding antibodies and uses thereof | |
| HK1202133A1 (en) | Kit comprising serum replacement and labile factors | |
| IL232399A0 (en) | Anti-fgfr2 antibodies and uses thereof | |
| IL229431A0 (en) | Anti-cgrp composition and use thereof | |
| EP2782601A4 (en) | Il-1 binding proteins | |
| ZA201400562B (en) | Axmi205 variant proteins and methods for their use | |
| EP2664671A4 (en) | Novel glycosyltransferase gene and use thereof | |
| EP2793021A4 (en) | Protein adsorbent | |
| EP2785738A4 (en) | Anti-npy and pyy antibodies and uses thereof | |
| EP2729758A4 (en) | Surrogate rpg | |
| HK1203232A1 (en) | Biomarker and use thereof | |
| GB2496392B (en) | Construction kit | |
| GB201120454D0 (en) | Kit and uses thereof | |
| GB201117881D0 (en) | Biomarkers and uses thereof | |
| HUP1100282A2 (en) | Protein factor | |
| IL213578A0 (en) | Sifter kit | |
| GB201120189D0 (en) | Construction kit | |
| GB201114341D0 (en) | Reagent and use | |
| GB201115151D0 (en) | Beverage kit | |
| PL394815A1 (en) | Experimental kit for testing the resonance curve | |
| GB201101021D0 (en) | Kit and method |